BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Liu R. Long non-coding RNA H19 in the liver-gut axis: A diagnostic marker and therapeutic target for liver diseases. Experimental and Molecular Pathology 2020;115:104472. [DOI: 10.1016/j.yexmp.2020.104472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zaiou M. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease. World J Gastroenterol 2022; 28(35): 5111-5128 [DOI: 10.3748/wjg.v28.i35.5111] [Reference Citation Analysis]
2 Qin R, Huang W, Huang Y, Zhang Z, Su Y, Chen S, Wang H. lncRNA MEG3 modulates hepatic stellate cell activation by sponging miR‑145 to regulate PPARγ. Mol Med Rep 2022;25:3. [PMID: 34738631 DOI: 10.3892/mmr.2021.12519] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Shen T, Lei T, Chen L, Zhu BB, Xu BL, Zhang CP, Wang HP. Gardenoside Hinders Caspase-1-Mediated Hepatocyte Pyroptosis Through the CTCF/DPP4 Signaling Pathway. Front Physiol 2021;12:669202. [PMID: 34566670 DOI: 10.3389/fphys.2021.669202] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Pieters A, Gijbels E, Cogliati B, Annaert P, Devisscher L, Vinken M. Biomarkers of cholestasis. Biomark Med 2021;15:437-54. [PMID: 33709780 DOI: 10.2217/bmm-2020-0691] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Liu TJ, Hu S, Qiu ZD, Liu D. Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review. Front Oncol 2020;10:634936. [PMID: 33680956 DOI: 10.3389/fonc.2020.634936] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Ma Y, Harris J, Li P, Cao H. Long noncoding RNAs-a new dimension in the molecular architecture of the bile acid/FXR pathway. Mol Cell Endocrinol 2021;525:111191. [PMID: 33539963 DOI: 10.1016/j.mce.2021.111191] [Reference Citation Analysis]
7 Suzuki T, Adachi S, Kikuguchi C, Shibata S, Nishijima S, Kawamoto Y, Iizuka Y, Koseki H, Okano H, Natsume T, Yamamoto T. Regulation of Fetal Genes by Transitions among RNA-Binding Proteins during Liver Development. Int J Mol Sci 2020;21:E9319. [PMID: 33297405 DOI: 10.3390/ijms21239319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, Fernandez-Barrena MG. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells 2020;9:E2321. [PMID: 33086678 DOI: 10.3390/cells9102321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]